Spero Therapeutics, Inc. (SPRO)
1.165
-0.02
(-2.10%)
USD |
NASDAQ |
Oct 07, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics EPS Diluted (Quarterly) : -0.1648 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1648 |
| March 31, 2026 | -0.1258 |
| December 31, 2025 | 0.5309 |
| September 30, 2025 | -0.1312 |
| June 30, 2025 | -0.0303 |
| March 31, 2025 | -0.2504 |
| December 31, 2024 | -0.383 |
| September 30, 2024 | -0.3168 |
| June 30, 2024 | -0.331 |
| March 31, 2024 | -0.2367 |
| December 31, 2023 | 0.9639 |
| September 30, 2023 | -0.0608 |
| June 30, 2023 | -0.2266 |
| March 31, 2023 | -0.2526 |
| December 31, 2022 | 0.5495 |
| September 30, 2022 | -0.3254 |
| June 30, 2022 | -0.8697 |
| March 31, 2022 | -1.007 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.9048 |
| September 30, 2021 | -0.7009 |
| June 30, 2021 | -0.6258 |
| March 31, 2021 | -0.6603 |
| December 31, 2020 | -0.679 |
| September 30, 2020 | -0.8633 |
| June 30, 2020 | -0.8482 |
| March 31, 2020 | -1.217 |
| December 31, 2019 | -1.311 |
| September 30, 2019 | -0.9495 |
| June 30, 2019 | -0.7443 |
| March 31, 2019 | -0.2945 |
| December 31, 2018 | -0.5976 |
| September 30, 2018 | -0.5989 |
| June 30, 2018 | -0.6925 |
| March 31, 2018 | -0.7408 |
| December 31, 2017 | -1.59 |
| September 30, 2017 | -36.02 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.0737 |
| Fortress Biotech, Inc. | -0.0779 |
| Kura Oncology, Inc. | -0.769 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.552M |
| Total Expenses (Quarterly) | 9.552M |
| Enterprise Value | 20.46M |
| Earnings Yield | 9.36% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | 10.000 |